(Q38010751)

26 August 2017

Pharmacogenetics of statins: achievements, whole-genome analyses and future perspectives (English)

1 reference

26 August 2017

whole genome sequencing

1 reference

7

Stella Trompet

1 reference

26 August 2017

4

P Eline Slagboom

1 reference

26 August 2017

5

Rudi G J Westendorp

1 reference

26 August 2017

6

J Wouter Jukema

1 reference

26 August 2017

3

Anton J M de Craen

1 reference

26 August 2017

1

Iris Postmus

1 reference

PubMed ID

22594514

26 August 2017

Jeffrey J W Verschuren

series ordinal

2

object named as

Jeffrey J W Verschuren

1 reference

26 August 2017

1 May 2012

1 reference

26 August 2017

1 reference

26 August 2017

13

1 reference

26 August 2017

7

1 reference

26 August 2017

831-840

1 reference

Recent trends in acute coronary heart disease--mortality, morbidity, medical care, and risk factors. The Minnesota Heart Survey Investigators.

26 August 2017

1 reference

Comparative effects of lipid-lowering therapies

21 January 2018

1 reference

Achieving greater reductions in cardiovascular risk: lessons from statin therapy on risk measures and risk reduction

21 January 2018

1 reference

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

21 January 2018

1 reference

Pharmacogenomics of cholesterol-lowering therapy

21 January 2018

1 reference

A systematic review on pharmacogenetics in cardiovascular disease: is it ready for clinical application?

21 January 2018

1 reference

Pharmacogenetic study of statin therapy and cholesterol reduction

21 January 2018

1 reference

Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease

21 January 2018

1 reference

APOE gene polymorphisms and response to statin therapy.

21 January 2018

1 reference

Pharmacogenetics of HMG-CoA reductase inhibitors: exploring the potential for genotype-based individualization of coronary heart disease management

21 January 2018

1 reference

ABCB1 haplotypes differentially affect the pharmacokinetics of the acid and lactone forms of simvastatin and atorvastatin.

21 January 2018

1 reference

The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy.

21 January 2018

1 reference

Clinical implications of pharmacogenomics of statin treatment

21 January 2018

1 reference

Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and coronary artery disease in 19 case-control studies

21 January 2018

1 reference

Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study.

21 January 2018

1 reference

Association of the Trp719Arg polymorphism in kinesin-like protein 6 with myocardial infarction and coronary heart disease in 2 prospective trials: the CARE and WOSCOPS trials.

21 January 2018

1 reference

KIF6 polymorphism as a predictor of risk of coronary events and of clinical event reduction by statin therapy.

21 January 2018

1 reference

A kinesin family member 6 variant is associated with coronary heart disease in the Women's Health Study

21 January 2018

1 reference

Five common gene variants identify elevated genetic risk for coronary heart disease

21 January 2018

1 reference

Association of gene variants with incident myocardial infarction in the Cardiovascular Health Study

21 January 2018

1 reference

KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER study

21 January 2018

1 reference

Surprises of the genome and "personalized" medicine

21 January 2018

1 reference

Clinical implications of pharmacogenetic variation on the effects of statins.

21 January 2018

1 reference

A polymorphism of the cholesteryl ester transfer protein gene predicts cardiovascular events in non-smokers in the West of Scotland Coronary Prevention Study

21 January 2018

1 reference

A prospective study of TaqIB polymorphism in the gene coding for cholesteryl ester transfer protein and risk of myocardial infarction in middle-aged men.

21 January 2018

1 reference

CETP genotype predicts increased mortality in statin-treated men with proven cardiovascular disease: an adverse pharmacogenetic interaction

21 January 2018

1 reference

Cholesteryl ester transfer protein TaqIB variant, high-density lipoprotein cholesterol levels, cardiovascular risk, and efficacy of pravastatin treatment: individual patient meta-analysis of 13,677 subjects.

21 January 2018

1 reference

Apolipoprotein-E polymorphism and response to pravastatin in men with coronary artery disease (REGRESS).

21 January 2018

1 reference

The effectiveness of hydroxy-methylglutaryl coenzyme A reductase inhibitors (statins) in the elderly is not influenced by apolipoprotein E genotype

21 January 2018

1 reference

Pharmacogenetic interactions between ABCB1 and SLCO1B1 tagging SNPs and the effectiveness of statins in the prevention of myocardial infarction

21 January 2018

1 reference

Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort

21 January 2018

1 reference

SLCO1B1 variants and statin-induced myopathy--a genomewide study

21 January 2018

1 reference

Genome-wide association of lipid-lowering response to statins in combined study populations

21 January 2018

1 reference

Replication of LDL GWAs hits in PROSPER/PHASE as validation for future (pharmaco)genetic analyses

21 January 2018

1 reference

Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes

21 January 2018

1 reference

Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators

21 January 2018

1 reference

Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts

21 January 2018

1 reference

Multi-Ethnic Study of Atherosclerosis: objectives and design

21 January 2018

1 reference

Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects

21 January 2018

1 reference

Variation in TCF7L2 influences therapeutic response to sulfonylureas: a GoDARTs study

21 January 2018

1 reference

High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome

21 January 2018

1 reference

Gene expression analysis of cardiovascular diseases: novel insights into biology and clinical applications

21 January 2018

1 reference

Implications of pharmacogenetics for individualizing drug treatment and for study design

21 January 2018

1 reference

From pharmacogenomic knowledge acquisition to clinical applications: the PharmGKB as a clinical pharmacogenomic biomarker resource

21 January 2018

1 reference

Variation in the 3-hydroxyl-3-methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment

21 January 2018

1 reference

The cholesteryl ester transfer protein Taq1B gene polymorphism predicts clinical benefit of statin therapy in patients with significant coronary artery disease

21 January 2018

1 reference

Regional Differences in Apolipoprotein E Polymorphism in Finland

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/PGS.12.25

1 reference

26 August 2017

1 reference

PubMed ID

22594514